Business · 24/10/1996
FDA Approves Guidant Corp.'s SELUTE Steroid Eluting Endocardial Lead Models 4185 and 4285
The US Food and Drug Administration (FDA) has granted premarket approval for Guidant Corp.'s SELUTE Steroid Eluting Endocardial Lead Models 4185 and 4285, following a notification from the FDA's Center for Devices and Radiological Health (CDRH) on May 8, 1996.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →